Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study

AIDS

Volumn 29, Issue 6, 2015, Pages 713-721

  Molsberry, Samantha A ^a   Lecci, Fabrizio ^b   Kingsley, Lawrence ^c   Junker, Brian ^b   Reynolds, Sandra ^d   Goodkin, Karl ^e   Levine, Andrew J ^f   Martin, Eileen ^g   Miller, Eric N ^h   Munro, Cynthia A ⁱ   Ragin, Ann ^j   Sacktor, Ned ^a   Becker, James T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e AIDS HEALTHCARE FOUNDATION   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g RUSH MEDICAL COLLEGE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

Dementia; Epidemiology; HIV; HIV associated neurocognitive disorder

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BISEXUAL MALE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; CONFOUNDING VARIABLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FOLLOW UP; HEPATITIS C; HIV ASSOCIATED DEMENTIA; HOMOSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTIMACY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIXED MEMBERSHIP TRAJECTORY MODEL; MULTICENTER STUDY; NEUROPSYCHOLOGY; PREMATURE AGING; PRIORITY JOURNAL; PROBABILITY; RACE; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL MODEL; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BISEXUALITY; CLINICAL TRIAL; COGNITION DISORDERS; COMPLICATION; HOMOSEXUALITY; MIDDLE AGED; VERY ELDERLY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BISEXUALITY; COGNITION DISORDERS; COHORT STUDIES; HOMOSEXUALITY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, STATISTICAL;

EID: 84937977290     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000561     Document Type: Article

References (33)

1. Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis 2013; 13:976-986.
2. Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med 2011; 19:137-142.
3. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69:1789-1799.
4. Liner KJ 2nd, Ro MJ, Robertson KR. HIV, antiretroviral therapies, and the brain. Curr HIV/AIDS Rep 2010; 7:85-91.
5. Al-Khindi T, Zakzanis KK, van Gorp WG. Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature. J Int Neuropsychol Soc 2011; 17:956-969.
6. Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ. Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J Neurovirol 2010; 16:101-114.
7. Spudich S. HIV and neurocognitive dysfunction. Curr HIV/AIDS Rep 2013; 10:235-243.
8. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011; 17:3-16.
9. De Ronchi D, Faranca I, Berardi D, Scudellari P, Borderi M, Manfredi R, et al. Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors. Arch Neurol 2002; 59:812-818.
10. Becker JT, Kingsley LA, Molsberry S, Reynolds S, Aronow A, Levine AJ, et al. Cohort profile: recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study. Int J Epidemiol 2014.
11. Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, et al. Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 2010; 75:1150-1158.
12. Vivithanaporn P, Nelles K, DeBlock L, Newman SC, Gill MJ, Power C. Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS. J Neurolog Sci 2012; 312:45-51.
13. McCutchan JA, Marquie-Beck JA, Fitzsimons CA, Letendre SL, Ellis RJ, Heaton RK, et al. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology 2012; 78:485-492.
14. Manrique-Vallier D, Fienberg S. Longitudinal mixed membership models with applications[dissertation]. Pittsburgh, PA: Carnegie-Mellon University Department of Statistics; 2010.
15. Manrique-Vallier D. Longitudinal Mixed Membership trajectory models for disability survey data. Ann Appl Stat 2014; 8:2268-2291.
16. Lecci F. An analysis of development of dementia through the extended trajectory grade of membership model. In: Airoldi EM, Blei D, E.A. E, Fienberg SE, editors. Handbook of mixed membership models. Chapman & Hall; 2014, ch. 10, pp. 189-200.
17. Connor JT. Multivariate mixture models to describe longitudinal patterns of frailty in American seniors [dissertation]. Pittsburgh, PA: Carnegie Mellon University, ProQuest, UMI Dissertations Publishing; 2006.
18. Erosheva E, Fienberg S, Joutard C. Describing disability through individual-level mixture models for multivariate binary data. Ann Appl Stat 2007; 1:502-537.
19. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR. The Multicenter AIDS Cohort Study (MACS): Rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126:310-318.
20. Kingsley LA, Detels R, Kaslow R, Polk BF, Rinaldo CR Jr, Chmiel J, et al. Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study. Lancet 1987; 1:345-349.
21. Miller EN, Selnes OA, McArthur MB. Neuropsychological test performance in HIV1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology 1990; 40:197-203.
22. Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 2004; 26:759-778.
23. Miller EN, Satz P, Visscher B. Computerized and conventional neuropsychological assessment of HIV1-infected homosexual men. Neurology 1991; 41:1608-1616.
24. Selnes OA, Miller EN. Development of a screening battery for HIV-related cognitive impairment: The MACS experience. In: Grant I, Martin A, editors. Neuropsychology of HIV infection New York: Oxford University Press; 1994. pp. 176-190.
25. Gelman A, Hill J. Data analysis using regression and multilevel/hierarchical models.Cambridge University Press; 2007.
26. Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol 2007; 64:97-102.
27. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, et al. Dementia in AIDS patients: incidence and risk factors. Neurology 1993; 43:2245-2253.
28. Watkins CC, Treisman GJ. Neuropsychiatric complications of aging with HIV. J Neurovirol 2012; 18:277-290.
29. Holt JL, Kraft-Terry SD, Chang L. Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol 2012; 18:291-302.
30. Zapata HJ, Shaw AC. Aging of the human innate immune system in HIV infection. Curr Opin Immunol 2014; 29C:127-136.
31. Becker JT, Butters N, Hermann A, D'Angelo N. A comparison of the effects of long-term alcohol abuse and aging on the performance of verbal and nonverbal divided attention tasks. Alcohol Clin Exp Res 1983; 7:213-219.
32. Lopez OL, Kuller LH, Fitzpatrick A, Ives D, Becker JT, Beauchamp N. Evaluations of dementia in the cardiovascular health cognition study. Neuroepidemiology 2003; 22:1-12.
33. McArthur J. Neurologic manifestations of AIDS. Medicine 1987; 66:407-437.